<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">These limitations of current vaccines emphasize the need to develop novel “universal” or “broadly protective” influenza vaccines. An ideal universal vaccine should cover all influenza A and influenza B viruses independent of antigenic drift or HA/neuraminidase (NA) subtype. In contrast, a broadly protective vaccine would cover a large subset of influenza viruses, for example, all human seasonal influenza virus strains. These two types of vaccines are generally referred to as “universal vaccines” (Memoli 
 <italic>et al.</italic>
 <xref ref-type="bibr" rid="CR73">2019</xref>).
</p>
